These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 15325474

  • 1. Use of pimobendan in the management of heart failure.
    Fuentes VL.
    Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1145-55. PubMed ID: 15325474
    [Abstract] [Full Text] [Related]

  • 2. Pimobendan and its use in treating canine congestive heart failure.
    Bowles D, Fry D.
    Compend Contin Educ Vet; 2011 Nov; 33(11):E1. PubMed ID: 22101450
    [Abstract] [Full Text] [Related]

  • 3. Use of pimobendan in 170 cats (2006-2010).
    Macgregor JM, Rush JE, Laste NJ, Malakoff RL, Cunningham SM, Aronow N, Hall DJ, Williams J, Price LL.
    J Vet Cardiol; 2011 Dec; 13(4):251-60. PubMed ID: 22030289
    [Abstract] [Full Text] [Related]

  • 4. A review of the pharmacology and clinical uses of pimobendan.
    Boyle KL, Leech E.
    J Vet Emerg Crit Care (San Antonio); 2012 Aug; 22(4):398-408. PubMed ID: 22928748
    [Abstract] [Full Text] [Related]

  • 5. Effect of oral administration of pimobendan in cats with heart failure.
    Gordon SG, Saunders AB, Roland RM, Winter RL, Drourr L, Achen SE, Hariu CD, Fries RC, Boggess MM, Miller MW.
    J Am Vet Med Assoc; 2012 Jul 01; 241(1):89-94. PubMed ID: 22720992
    [Abstract] [Full Text] [Related]

  • 6. [Pimobendan (UDCG 115 BS) in long-term therapy of chronic heart failure].
    Bergler-Klein J, Globits S, Stefenelli T, Mayr H, Porenta G, Sochor H, Glogar D.
    Z Kardiol; 1992 Oct 01; 81(10):546-52. PubMed ID: 1441695
    [Abstract] [Full Text] [Related]

  • 7. Pimobendan in heart failure therapy--a silver bullet?
    Gordon SG, Miller MW, Saunders AB.
    J Am Anim Hosp Assoc; 2006 Oct 01; 42(2):90-3. PubMed ID: 16527909
    [Abstract] [Full Text] [Related]

  • 8. Current use of pimobendan in canine patients with heart disease.
    Boswood A.
    Vet Clin North Am Small Anim Pract; 2010 Jul 01; 40(4):571-80. PubMed ID: 20610012
    [Abstract] [Full Text] [Related]

  • 9. Inodilator therapy for heart failure. Early, late, or not at all?
    Remme WJ.
    Circulation; 1993 May 01; 87(5 Suppl):IV97-107. PubMed ID: 8097971
    [Abstract] [Full Text] [Related]

  • 10. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA, Singh MK, Kass PH, Griffiths LG.
    J Vet Cardiol; 2015 Jun 01; 17(2):120-8. PubMed ID: 26007710
    [Abstract] [Full Text] [Related]

  • 11. Treatment of congestive heart failure.
    Butson R.
    J Small Anim Pract; 2003 Nov 01; 44(11):516. PubMed ID: 14635966
    [No Abstract] [Full Text] [Related]

  • 12. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR, Minors SL, O'Sullivan ML, Horne R.
    J Vet Intern Med; 2008 Nov 01; 22(4):897-904. PubMed ID: 18537880
    [Abstract] [Full Text] [Related]

  • 13. Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.
    Fitton A, Brogden RN.
    Drugs Aging; 1994 May 01; 4(5):417-41. PubMed ID: 8043944
    [Abstract] [Full Text] [Related]

  • 14. Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure.
    Reina-Doreste Y, Stern JA, Keene BW, Tou SP, Atkins CE, DeFrancesco TC, Ames MK, Hodge TE, Meurs KM.
    J Am Vet Med Assoc; 2014 Sep 01; 245(5):534-9. PubMed ID: 25148095
    [Abstract] [Full Text] [Related]

  • 15. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kovacević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, O'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2008 Sep 01; 22(5):1124-35. PubMed ID: 18638016
    [Abstract] [Full Text] [Related]

  • 16. Inotropic agents with calcium-sensitizing properties: clinical and hemodynamic effects of pimobendan.
    Kubo SH.
    Coron Artery Dis; 1994 Feb 01; 5(2):119-26. PubMed ID: 8180743
    [No Abstract] [Full Text] [Related]

  • 17. Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.
    Boswood A, McEwan JD, French A, Little C, Swift S, Smith S, Patteson M.
    Vet Rec; 2003 Oct 04; 153(14):439-40. PubMed ID: 14582738
    [No Abstract] [Full Text] [Related]

  • 18. Use of pimobendan in feline congenital heart failure.
    Wainberg S.
    Can Vet J; 2013 Dec 04; 54(12):1164-6. PubMed ID: 24293678
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013 Dec 04; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

  • 20. [Phosphodiesterase inhibition as a new positive-inotropic principle].
    Hartmann A, Saeed M, Sütsch G, Bing RJ.
    Dtsch Med Wochenschr; 1986 Dec 19; 111(51-52):1971-7. PubMed ID: 3539571
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.